Full-year 2025 revenue and adjusted EBITDA guidance were raised, reflecting strong commercial execution and new product launches. These 10 stocks could mint the next wave of millionaires › Exact ...

The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses ...